# Veratridine

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/veratridine
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** Sabadilla alkaloid, Veratrum alkaloid, Schoenocaulon alkaloid, Steroidal neurotoxin alkaloid, Sabadinine derivative, White hellebore alkaloid

## Overview

Veratridine is a steroidal alkaloid derived from Veratrum species plants that acts as a potent activator of voltage-gated sodium channels (Nav), preventing their inactivation and causing persistent depolarization of excitable cells. It is classified strictly as a research-grade neurotoxin with no approved therapeutic or dietary supplement applications in humans.

## Health Benefits

• No therapeutic benefits established - veratridine is a neurotoxin with no approved clinical uses (no human trials)
• Research tool only - used to study sodium channel dynamics in laboratory settings (in vitro evidence only)
• Preclinical cancer research - showed potential chemosensitivity enhancement through mortalin-2 inhibition (cell studies only, Abdullah et al. 2015)
• Potential Nav1.7 channel inhibition suggesting theoretical analgesic properties (mechanistic studies only, not pursued clinically)
• Historical pesticide use - toxicity exploited for agricultural pest control, not human health

## Mechanism of Action

Veratridine binds to site 2 of voltage-gated sodium channels (Nav1.x isoforms), specifically interacting with transmembrane segments IS6 and IVS6, locking channels in a persistently open conformation and blocking fast inactivation. This sustained sodium influx causes continuous membrane depolarization, triggering excessive [neurotransmitter release](/ingredients/condition/cognitive), particularly catecholamines such as norepinephrine and [dopamine](/ingredients/condition/mood), from nerve terminals. At the cellular level, the resultant Na+ overload drives secondary Ca2+ entry via reverse-mode Na+/Ca2+ exchange, ultimately leading to cytotoxicity and cell death.

## Clinical Summary

There are zero published randomized controlled trials or approved human clinical studies investigating veratridine as a therapeutic agent. All available evidence originates from in vitro cell-based assays and rodent models; for example, preclinical studies in murine cancer cell lines demonstrated that veratridine enhanced chemosensitivity to agents like doxorubicin, but no human translation has been pursued. A small number of animal electrophysiology studies used veratridine at nanomolar concentrations (typically 10–100 nM) to characterize Nav isoform pharmacology, confirming its utility as a mechanistic probe rather than a drug candidate. The overall evidence base is exclusively preclinical, and no dosing regimen, bioavailability data, or efficacy endpoint has been established for humans.

## Nutritional Profile

Veratridine is a steroidal alkaloid (C36H51NO11, molecular weight 673.79 g/mol) isolated from Veratrum album (white hellebore) and Schoenocaulon officinale (sabadilla seeds) — it is a pure pharmacologically active compound with no nutritional value. Macronutrient classification: not applicable as a food ingredient. Contains no dietary protein, carbohydrates, fiber, vitamins, or minerals in any meaningful nutritional sense. As a steroidal alkaloid, it possesses a lipid-soluble polycyclic carbon skeleton structurally related to cholesterol-derived compounds, but contributes no caloric value in any established dietary context. Bioactive compound concentration in source plants: veratridine constitutes approximately 0.2–1.5% of total alkaloid content in Veratrum species, with total plant alkaloid content ranging 0.5–2.0% dry weight. The compound is highly bioavailable due to lipophilicity (estimated logP ~2.5–3.5), readily crossing biological membranes including the blood-brain barrier. Oral absorption is documented but precise human bioavailability data is absent due to toxicity precluding human pharmacokinetic studies. In laboratory preparations, veratridine is typically handled as a pure isolated compound (>98% purity) dissolved in DMSO or ethanol at concentrations of 1–10 mM stock solutions. No Dietary Reference Intake (DRI), Tolerable Upper Limit, or nutritional recommendation exists — the compound is classified as a neurotoxin with a lethal dose (LD50) of approximately 1.35 mg/kg (intravenous, mouse model).

## Dosage & Preparation

No clinically established dosage exists - veratridine is a neurotoxin contraindicated for human consumption. Research concentrations use micromolar ranges in cell culture and mg/kg doses in animal studies, but these are not therapeutic recommendations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Veratridine is acutely toxic to humans even at low doses; ingestion of Veratrum-containing plants has caused severe bradycardia, hypotension, prolonged QT interval, ventricular arrhythmias, and respiratory depression requiring emergency intervention. It has no established safe human dose, and accidental poisoning cases report symptom onset within 30 minutes of exposure involving nausea, vomiting, paraesthesia, and [cardiovascular](/ingredients/condition/heart-health) collapse. Veratridine would be expected to dangerously potentiate the effects of other sodium channel-active drugs including local anesthetics (lidocaine, bupivacaine), antiepileptics (carbamazepine, phenytoin), and antiarrhythmics. It is absolutely contraindicated in pregnancy, nursing, pediatric populations, and any individual with cardiovascular, neurological, or renal conditions, and it should never be self-administered or purchased as a supplement.

## Scientific Research

No human clinical trials or RCTs exist for veratridine - it is not approved for clinical use. The only published biomedical research is a preclinical oncology study (Abdullah et al., Oncotarget 2015;6(27):23561-81) demonstrating UBXN2A-dependent mortalin-2 inhibition in cell models. All other evidence consists of in vitro pharmacological characterization studies using veratridine as a research tool.

## Historical & Cultural Context

Unlike many plant alkaloids, veratridine has minimal documented use in traditional medicine systems due to its recognized toxicity. Veratrum and Schoenocaulon plants were historically used as insecticides and pesticides in agricultural settings. 19th-century pharmaceutical experiments with veratridine for hypertension were abandoned due to its narrow therapeutic window and severe toxicity.

## Synergistic Combinations

Not applicable - toxic compound with no therapeutic uses

## Frequently Asked Questions

### Is veratridine safe to take as a supplement?

No — veratridine is a classified neurotoxin and is not approved, sold, or safe for use as a dietary supplement in humans. Even small quantities can trigger life-threatening cardiovascular events including severe bradycardia and ventricular arrhythmias, as documented in Veratrum plant poisoning case reports. It exists solely as a laboratory reagent for research purposes.

### What plant does veratridine come from?

Veratridine is a steroidal alkaloid isolated primarily from plants in the Veratrum genus, particularly Veratrum album (white hellebore) and Veratrum viride (American false hellebore), as well as Schoenocaulon officinale (sabadilla). These plants contain a mixture of toxic alkaloids including cevadine and jervine alongside veratridine, and have historically caused accidental poisoning when mistaken for edible plants like wild garlic or ramps.

### How does veratridine affect sodium channels?

Veratridine binds to site 2 on voltage-gated sodium channels (Nav1.x), specifically locking the channel in an open state by preventing the fast inactivation gate — formed by the DIII-DIV linker — from closing. This causes a persistent, non-inactivating sodium current that continuously depolarizes neurons and muscle cells. The result is uncontrolled firing of action potentials, excessive neurotransmitter release, and eventual excitotoxic cell death at higher concentrations.

### Has veratridine been studied in cancer research?

Veratridine has been investigated in preclinical, in vitro cancer studies where it demonstrated the ability to sensitize certain tumor cell lines — including breast and colorectal cancer cells — to chemotherapy agents like doxorubicin, potentially through Nav1.5 channel modulation that disrupts tumor cell migration and invasion. However, all findings are limited to cell culture experiments; no animal efficacy studies or human trials exist, and the compound's extreme toxicity profile makes clinical development highly unlikely.

### What are the symptoms of veratridine or Veratrum poisoning?

Symptoms of veratridine toxicity typically appear within 15–60 minutes of ingestion and include intense salivation, nausea, vomiting, abdominal pain, and a characteristic burning sensation in the mouth and throat. Systemic effects progress to severe bradycardia (heart rate can drop below 40 bpm), hypotension, prolonged QT interval, muscle weakness, and in serious cases ventricular arrhythmias or respiratory failure. Treatment is supportive and may require atropine for bradycardia and vasopressors for hemodynamic instability, with monitoring in an emergency care setting.

### What is the difference between veratridine used in research versus other sodium channel modulators?

Veratridine is a steroidal alkaloid that keeps sodium channels in a permanently open state, making it uniquely valuable for studying prolonged sodium influx in laboratory settings. Unlike pharmaceutical sodium channel blockers designed for clinical use, veratridine is too toxic for human administration and is used exclusively as a research tool to understand sodium channel biophysics and neuronal signaling dynamics. Other modulators like tetrodotoxin block channels, whereas veratridine's activation mechanism provides different experimental insights into channel behavior.

### Why is veratridine unsuitable as a supplement despite promising preclinical cancer findings?

While veratridine showed potential to enhance chemosensitivity in cell culture studies through mortalin-2 inhibition, no human clinical trials have ever been conducted, and the compound's neurotoxic effects prevent safe supplementation. The gap between in vitro cancer cell research and human efficacy and safety is substantial, and veratridine's systemic toxicity would likely outweigh any theoretical benefit. Regulatory agencies have not approved veratridine for any human therapeutic use due to these safety concerns.

### What makes veratridine a preferred research tool compared to other sodium channel investigation methods?

Veratridine's ability to persistently activate sodium channels at physiologically relevant concentrations makes it exceptionally useful for studying the consequences of prolonged sodium ion entry in isolated tissues and cell preparations. Its mechanism is more selective for sodium channels than general depolarizing agents, allowing researchers to isolate channel-specific effects without confounding variables from other ion channels. This specificity has made veratridine a standard laboratory reagent in electrophysiology and neuroscience research since the 1970s.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*